Beiersdorf has reported organic sales growth of 11.2% year-on-year, to €7.3 billion, in the first nine months of its financial year.
The German group's consumer business unit reported organic sales growth of 13.6%, to €6.0 billion.
Beiersdorf added that its growth was driven by the good performance of its Nivea brand and the Derma business, which includes the brands Eucerin and Aquaphor.
The tesa segment saw organic growth of 1.3% year on year, amounting to €1.3 billion in the first nine months.
'Outstanding Results'
Vincent Warnery, CEO of Beiersdorf stated, "These outstanding results are a true testament to the effective strategic digitalisation and globalisation of our brand portfolio and were additionally fuelled by strong innovations and our pipeline of sustainable products.
"This achievement reinforces our continued growth ambition, and we are therefore raising our sales guidance for the full year."
Full-Year Outlook
At group level, Beiersdorf raised its sales guidance and has forecast low-double-digit organic sales growth for the full year.
The Nivea maker has also confirmed that it expects an EBIT margin, excluding special factors, slightly above the previous year‘s level.
The company now expects low-double-digit organic sales growth for the consumer business segment for the full year and confirmed its forecast for an EBIT margin 50bps higher than in the previous year.
For the tesa business unit, organic sales growth is expected to remain in the low- to mid-single digit range for the full year.
The group also confirmed that the unit's EBIT margin, excluding special factors will remain slightly below the previous year‘s level.
Highlights
In the consumer segment, the Nivea brand, including Labello, continued to outperform the market with broad-based growth of 17.5% in the first nine months.
All regions achieved double-digit growth, as did both the personal and skin care categories and all main sub-categories.
Its Derma brands Eucerin and Aquaphor saw organic sales growth of 24.8% in the first nine months of 2023, driven by the performance of the Sun Care product range, continued growth of the e-commerce business, and the performance of the Derma portfolio in Latin America.
Multiple product launches, many of them featuring the ingredient Thiamidol, contributed significantly to the overall growth and helped to strengthen Beiersdorf’s position in various markets.
Elsewhere, premium brand La Prairie saw sales decline by 15.8% in this period.
The company's healthcare business, which mainly comprises the plaster business of Hansaplast and Elastoplast, recorded organic sales growth of 4.3% against a strong performance in the same period last year.
